September 18th
Open call for original research articles and current reviews dedicated to the development and application of animal models in radiotherapy research for publication in Cancers.
Animal models are essential tools in radiotherapy research that have played critical roles in developing our understanding of tumour and normal tissue response. With recent advances in small animal irradiation techniques, preclinical imaging and genome editing, animal models continue to evolve to better recapitulate radiation response in humans.
These developments are allowing previously unimaginable experimental approaches to be used in the laboratory, and have much potential towards the development of biologically optimized treatment strategies.
Cancers, the peer reviewed open access journal, is requesting submissions for original research articles and current reviews dedicated to the development and application of animal models in radiotherapy research, such as those done on the Small Animal Radiation Research Platform.
“This special issue aims to highlight the state-of-the-art in modeling radiotherapy response in animal models, and to demonstrate the broad range of experimental approaches currently being explored. Importantly, we also aim to provide a critical discussion on the translational relevance of animal models and their potential to drive innovations in the clinic.” Dr Karl Butterworth, guest editor.
To find out more, or to submit your research follow the link to Cancers Special Issue website. Please note the deadline is the 15th December 2019.
XBeam from Xstrahl Receives U.S. Food and Drug Administration (FDA) 510(k) Clearance for Use in the U.S.
Xstrahl’s XBeam has received FDA 510(k) Clearance for Use in the U.S. The XBeam technology streamlines radiotherapy treatment planning and simplifies patient workflow for treating skin cancer, benign diseases, and palliative care. Explore how this innovation enhances orthovoltage superficial radiotherapy (SRT) and electronic brachytherapy (eBt). With XBeam, you can calculate, protocol and export treatment plans for Xstrahl treatments with Radiant Aura and all other Xstrahl medical devices in the U.S. and worldwide.
